Chirurgická léčba vrozených srdečních vad včera a dnes

Tomáš Tláskal

Cor Vasa 2009, 51(5):320-321  

Aortic valve replacement in patients over 80 years of age

Marek Adamíra, Petr Juštík, Jan Pirk, Ivo Skalský, Tomáš Kotulák, Věra Lánská

Cor Vasa 2009, 51(5):322-326 | DOI: 10.33678/cor.2009.085  

Aim: To evaluate the outcomes of aortic valve replacement in patients over 80 years of age.Methods: In the 1997-2007 period, a total of 91 patients aged over 80 years had surgery at the Department of Cardiac Surgery of the Institute for Clinical and Experimental Medicine. Both early (30-day) and late mortality of these patients undergoing aortic valve replacement was assessed. Using statistical methods, an attempt was made to identify risk factors involved in early and late mortality and, also, independent risk factors for late mortality.Results: Early and late mortality was 6.6% and 28.6%, respectively, with a mean follow-up period of 33 months....

Delayed sternal closure in newborns after surgery for congenital heart defect

Pavel Vojtovič, Tomáš Tláskal, Marek Selko, Oleg Reich, Roman Gebauer, Bohumil Hučín, Tomáš Matějka, Jiří Hostaša, Jan Škovránek

Cor Vasa 2009, 51(5):327-333 | DOI: 10.33678/cor.2009.086  

Background: Primary sternal closure after surgery for congenital heart defect is not feasible in all newborns because of tissue swelling, cardiomegaly, or postoperative bleeding. Therefore, in selected patients, the method of delayed sternal closure has been used to prevent low cardiac output, primarily in the operating theatre. Delayed sternal closure has also been used in the early postoperative period in patients with low cardiac output or after successful cardiopulmonary resuscitation at the cardiac intensive care unit.Objective: Retrospective analysis of incidence, indication, used techniques, and complications of delayed sternal closure in...

The contribution of real-time three-dimensional transesophageal echocardiography to intraoperative diagnosis in mitral regurgitant lesions

Josef Nečas, Sylva Kovalová, Helena Bedáňová, Petr Pokorný, Pavel Útrata, Jan Černý, Petr Němec, Jiří Ondrášek, Martin Hála

Cor Vasa 2009, 51(5):334-339 | DOI: 10.33678/cor.2009.087  

Aim: To introduce a novel modality, real-time three dimensional transesophageal echocardiography (RT 3D TEE), into clinical practice and to evaluate its feasibility and impact on intraoperative morphological and hemodynamic diagnosis in mitral regurgitant lesions.Material and method: During the year 2008, a total of 88 patients were investigated intraoperatively by RT 3D TEE together with conventional 2D method. The patient group comprised 57 men and 31 women with a wide variety of mitral regurgitant lesions (predominantly degenerative and ischemic). RT 3D TEE was carried out before and repeated immediately after heart surgery. We used "live" 3D...

Diagnosing of coronary heart disease in patients with diabetes

Vilém Danzig, Stanislav Šimek, Valérie Knotková, Michael Aschermann

Cor Vasa 2009, 51(5):340-347 | DOI: 10.33678/cor.2009.088  

Coronary heart disease (CHD) is the most common and serious cause of morbidity and in patients with diabetes mellitus already before the diagnosis has been established. Diagnosing CHD, not always a simple procedure per se, is associated with additional problems in population with diabetes, particularly because of the frequent presence of asymptomatic forms. Routinely used methods of examination include resting and exercise electrocardiography (ECG), echocardiography including stress echocardiography, nuclear medicine procedures, computed tomography, and magnetic resonance imaging. The latter three are of paramount importance in the population of patients...

Embolic complications of prosthetic valve endocarditis

Ľubomír Bunček, Jiří Vondrák, Petr Vojtíšek, Jan Studnička

Cor Vasa 2009, 51(5):348-349 | DOI: 10.33678/cor.2009.089  

Infectious endocarditis remains to be a serious, life-threatening condition even today. Mortality is increased, exceeding 30%, with endocarditis involving prosthetic valves. The authors present the case of prosthetic valve endocarditis involving the aortic valve prosthesis with embolic complications resulting in deterioration of the patient's condition and, eventually, his death.

A case report of acute perimyocarditis

Mikuláš Mészáros, Petr Černý

Cor Vasa 2009, 51(5):350-353 | DOI: 10.33678/cor.2009.090  

We report the case of acute perimyocarditis in a 20-year-old man showing typical clinical and laboratory symptoms and having a favorable course of disease.

Secondary hypertension in prolactinoma

Karel Riegel

Cor Vasa 2009, 51(5):354-357 | DOI: 10.33678/cor.2009.091  

The paper presents the case report of a young male patient with severe systemic hypertension caused by increased intracranial blood pressure due to a large prolactinoma. The patient experienced sight impairment due to local oppression by the tumor, had left ventricular hypertrophy and hypertension-induced renal failure. Anti-edema therapy was associated with partial remission of the presentations of intracranial hypertension. The prolactinoma was treated conservatively with carbegoline; contrary to expectations, the observed regression in tumor size was not significant. Antihypertensive therapy was fairly complicated given the slowly resolving intracranial...

Milan Cholt: Sonografie velkých krčních cév

Prof. MUDr. Jan Petrášek, DrSc.

Cor Vasa 2009, 51(5):374  

Membranózní defekt komorového septa s hemodynamikou defektu Gerbodeho typu při perforaci septálního cípu trikuspidální chlopně

Tomáš Paleček, Jaroslav Lindner, František Mlejnský, David Ambrož, Petr Vondráček, Aleš Linhart

Cor Vasa 2009, 51(5):358-359 | DOI: 10.33678/cor.2009.092  

Use of trimetazidine in the treatment of cardiac ischemia

Jiří Krupička

Cor Vasa 2009, 51(5):360-364 | DOI: 10.33678/cor.2009.093  

Trimetazidine improves the metabolism of the ischemic myocardium at the cellular level. In patients with stable angina, it reduces the frequency of anginal attacks and nitrate consumption while increasing exercise tolerance. Because of trimetazidine's additive action, it can be combined with advantage with other antianginal agents. As the agent has no effects on hemodynamic parameters, undesirable effects are negligible. Regarding other indications, no decisions can be made until data from large trials have become available.

"An old friend is still at work"

MUDr. Milan Frélich,

Cor Vasa 2009, 51(5):366-367  

Prof. MUDr. Miloš Štejfa, DrSc., FESC (*28. 5. 1929)

Jiří Vítovec, Jindřich Špinar

Cor Vasa 2009, 51(5):368-369  

Taktika a strategie kontroly rizik kardiovaskulárního kontinua

Cor Vasa 2009, 51(5):370-372  

Zpráva o zahraniční cestě podporované Českou kardiologickou společností

MUDr. Roman Miklík

Cor Vasa 2009, 51(5):375-376  

Kalendář odborných akcí

Cor Vasa 2009, 51(5):378-380